Frontiers in Cardiovascular Medicine (Jul 2024)

Artificial intelligence-enabled atrial fibrillation detection using smartwatches: current status and future perspectives

  • Zoi Papalamprakopoulou,
  • Dimitrios Stavropoulos,
  • Serafeim Moustakidis,
  • Dimitrios Avgerinos,
  • Michael Efremidis,
  • Polydoros N. Kampaktsis

DOI
https://doi.org/10.3389/fcvm.2024.1432876
Journal volume & issue
Vol. 11

Abstract

Read online

Atrial fibrillation (AF) significantly increases the risk of stroke and heart failure, but is frequently asymptomatic and intermittent; therefore, its timely diagnosis poses challenges. Early detection in selected patients may aid in stroke prevention and mitigate structural heart complications through prompt intervention. Smartwatches, coupled with powerful artificial intelligence (AI)-enabled algorithms, offer a promising tool for early detection due to their widespread use, easiness of use, and potential cost-effectiveness. Commercially available smartwatches have gained clearance from the FDA to detect AF and are becoming increasingly popular. Despite their promise, the evolving landscape of AI-enabled smartwatch-based AF detection raises questions about the clinical value of this technology. Following the ongoing digital transformation of healthcare, clinicians should familiarize themselves with how AI-enabled smartwatches function in AF detection and navigate their role in clinical settings to deliver optimal patient care. In this review, we provide a concise overview of the characteristics of AI-enabled smartwatch algorithms, their diagnostic performance, clinical value, limitations, and discuss future perspectives in AF diagnosis.

Keywords